Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III)

NCT06832917 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
238
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Wan He